Related Experiment Video
Updated: May 20, 2026

10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Improved parkinsonism diagnosis using a partial least squares based approach
F Segovia1, J M Gorriz, J Ramirez
1Department of Signal Theory, Networking and Communications, University of Granada, Granada, Spain. fsegovia@ugr.es
Medical Physics
|July 27, 2012
Summary
A new method using (123)I-ioflupane brain imaging accurately distinguishes Parkinsonian syndrome (PS) from controls. This approach improves diagnostic accuracy for complex neurological conditions.
Area of Science:
- Neurology
- Medical Imaging
- Machine Learning
Background:
- Diagnosing Parkinsonian syndrome (PS) is challenging due to overlapping symptoms across various conditions.
- Accurate and early diagnosis is crucial for effective patient management.
- (123)I-ioflupane SPECT imaging offers potential for improved in vivo assessment of neurodegenerative disorders.
Purpose of the Study:
- To develop and validate a novel automated method for classifying (123)I-ioflupane brain images.
- To differentiate between controls and patients with Parkinsonian syndrome (PS).
- To enhance the accuracy of PS diagnosis using advanced imaging analysis.
Main Methods:
- A novel classification methodology was developed analyzing each brain hemisphere separately.
- The approach integrates Partial Least Squares (PLS) for feature extraction and Support Vector Machines (SVM) for classification.
- The method was evaluated on a database of 189 (123)I-ioflupane SPECT images.
Main Results:
- The proposed PLS-based method achieved high diagnostic performance.
- Accuracy reached 94.7%, with sensitivity of 93.7% and specificity of 95.7%.
- This method outperformed previous approaches utilizing singular value decomposition.
Conclusions:
- Applying advanced signal analysis techniques to individual brain hemispheres significantly improves assisted diagnosis of PS.
- The developed method offers a robust tool for differentiating PS from healthy controls.
- This technique holds promise for earlier and more accurate detection of Parkinsonian syndromes.
Related Concept Videos
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...

